Using Oral and Intranasal Dosage Forms of Ketamine for Managing Treatment-Resistant Depression: A Review of the Literature

A lack of effective treatment for patients with treatment-resistant depression (TRD) has led to the evaluation of ketamine, an N-methyl- D-aspartate receptor antagonist. Despite the demonstrated short-term benefits of using intravenous (IV) ketamine, side effects and the difficulty in administering...

Full description

Bibliographic Details
Main Authors: Patrick Arthur Twohig, Vaughn Huckfeldt
Format: Article
Language:English
Published: University Library System, University of Pittsburgh 2016-07-01
Series:International Journal of Medical Students
Subjects:
Online Access:http://ijms.info/IJMS/article/view/153